Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.29 | N/A |
| PEG Ratio (TTM) | -0.76 | N/A |
| P/S Ratio (TTM) | 3.93 | N/A |
| P/B Ratio (TTM) | 1.52 | N/A |
| P/FCF Ratio (TTM) | 11.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.10 | N/A |
| Price to 5YR AVG FCF Ratio | 2.51 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 14.88% | N/A |
| ROE (TTM) | 21.39% | N/A |
| Net Profit Margin (TTM) | 26.03% | N/A |
| ROIC 5YR AVG | 18.43% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -27.93% | 48.69% | 42.93% |
| Revenue | -0.95% | 10.50% | 9.77% |
| Net Income | -3.69% | 49.41% | 42.70% |
| Cash Flow | 7.79% | 24.35% | 22.34% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.08 | N/A |
| Quick Ratio (TTM) | 3.06 | N/A |
| D/E Ratio (TTM) | 0.08 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.46 | N/A |
| LTL to 5YR AVG FCF | 0.04 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.10% | N/A |